Aridis Pharmaceuticals Inc (ARDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 35 | 19 | 1,320 | 5,059 | 2,633 |
| Receivables | 517 | 300 | 100 | 1,240 | 248 |
| Other current assets | 0 | 0 | 1,986 | 1,986 | 1,986 |
| TOTAL | $4,110 | $3,884 | $6,566 | $11,626 | $8,635 |
| Non-Current Assets | |||||
| PPE Net | 511 | 569 | 645 | 730 | 974 |
| Intangibles | 13 | 14 | 15 | 17 | 18 |
| Other Non-Current Assets | 1,900 | 2,015 | 2,208 | 2,322 | 2,493 |
| TOTAL | $2,424 | $2,598 | $2,868 | $3,069 | $3,485 |
| Total Assets | $6,534 | $6,482 | $9,434 | $14,695 | $12,120 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,410 | 6,237 | 4,119 | 2,308 | 4,230 |
| Accrued Expenses | 7,691 | 8,461 | 9,408 | 9,564 | 8,494 |
| Other current liabilities | 395 | 403 | 15 | 20,188 | 15 |
| TOTAL | $17,482 | $20,394 | $35,431 | $36,898 | $42,277 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 3,499 |
| Deferred Revenues | N/A | N/A | 19,091 | N/A | 20,386 |
| Other Non-Current Liabilities | 854 | 1,002 | 1,148 | 2,029 | 1,430 |
| TOTAL | $854 | $1,002 | $1,885 | $2,029 | $5,666 |
| Total Liabilities | $18,336 | $21,396 | $37,316 | $38,927 | $47,943 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,574 | 36,078 | 36,078 | 36,078 | 20,805 |
| Common Shares | 5 | 4 | 4 | 3 | 2 |
| Retained earnings | -190,421 | -190,338 | -202,482 | -195,666 | -189,279 |
| Other shareholders' equity | 7,787 | 6,526 | 5,912 | 5,051 | 0 |
| TOTAL | $-11,802 | $-14,914 | $-27,882 | $-24,232 | $-35,823 |
| Total Liabilities And Equity | $6,534 | $6,482 | $9,434 | $14,695 | $12,120 |